Cue Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. Thank you for coming today for the Morgan Stanley Healthcare Conference. Today, this afternoon, I have with me Dan Passeri, the CEO of Cue. And why don't I pass it off to Dan to introduce the rest of the management team? The format here will be a 10-minute overview of the company followed by a Q&A led by me. (Operator Instructions) Dan?
Okay. Thanks, Albert. Good afternoon, everyone. I'm joined here by -- with my colleague, Anish Suri, who's President and Chief Scientific Officer of Cue Biopharma.
Just to remind everyone, Cue is a NASDAQ-listed company. Symbol is CUE. I also want to thank Morgan Stanley for giving us an opportunity to present.
I'm going to be advancing slides here at our facility, and I'll tell you which slides we're on. You can advance them off of your computers directly.
We're now moving to Slide 2.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |